Back to Search Start Over

G-quadruplex structural variations in human genome associated with single-nucleotide variations and their impact on gene activity

Authors :
Juan-Nan Chen
Cui-Jiao Wen
Ming-Liang Tang
Jia-Yuan Gong
Zheng Tan
Rui-Fang Duan
Yu-hua Hao
Yi-de He
Jia-yu Zhang
Ke-wei Zheng
Su-Ping Ren
Qun Yu
Source :
Proc Natl Acad Sci U S A
Publication Year :
2021
Publisher :
Proceedings of the National Academy of Sciences, 2021.

Abstract

G-quadruplexes (G4s) formed by guanine-rich nucleic acids play a role in essential biological processes such as transcription and replication. Besides the >1.5 million putative G-4–forming sequences (PQSs), the human genome features >640 million single-nucleotide variations (SNVs), the most common type of genetic variation among people or populations. An SNV may alter a G4 structure when it falls within a PQS motif. To date, genome-wide PQS–SNV interactions and their impact have not been investigated. Herein, we present a study on the PQS–SNV interactions and the impact they can bring to G4 structures and, subsequently, gene expressions. Based on build 154 of the Single Nucleotide Polymorphism Database (dbSNP), we identified 5 million gains/losses or structural conversions of G4s that can be caused by the SNVs. Of these G4 variations (G4Vs), 3.4 million are within genes, resulting in an average load of >120 G4Vs per gene, preferentially enriched near the transcription start site. Moreover, >80% of the G4Vs overlap with transcription factor–binding sites and >14% with enhancers, giving an average load of 3 and 7.5 for the two regulatory elements, respectively. Our experiments show that such G4Vs can significantly influence the expression of their host genes. These results reveal genome-wide G4Vs and their impact on gene activity, emphasizing an understanding of genetic variation, from a structural perspective, of their physiological function and pathological implications. The G4Vs may also provide a unique category of drug targets for individualized therapeutics, health risk assessment, and drug development.

Details

ISSN :
10916490 and 00278424
Volume :
118
Database :
OpenAIRE
Journal :
Proceedings of the National Academy of Sciences
Accession number :
edsair.doi.dedup.....e13956de9ba46cccb9e638a4a9f3e61f